Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;18(4):1058-1060.
doi: 10.1038/s41423-021-00641-8. Epub 2021 Feb 12.

Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques

Affiliations

Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques

Rong Li et al. Cell Mol Immunol. 2021 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Neutralizing potential of sera from convalescent patients and RBD nanoparticle-vaccinated rhesus macaques against SARS-CoV-2 variants. a Schematic of the spike protein of SARS-CoV-2 variants, including G614, D614, B.1.1.7, and 501Y.V2. Mutation types and positions are indicated next to each backbone. b Different pseudotyped viruses were incubated with serially diluted sera from convalescent COVID-19 patients and healthy controls to detect neutralizing antibodies. Neutralization potency was calculated by measuring the luciferase activity of infected hACE2-HeLa cells and plotted as a neutralization curve. Black lines represent the sera from healthy donors. c NT50 of each convalescent serum against each pseudotyped virus. d Different pseudotyped viruses were incubated with serially diluted sera from nanoparticle-vaccinated rhesus macaques to detect neutralizing antibodies. Neutralization potency was plotted as a neutralization curve. e NT50 of each serum from nanoparticle-vaccinated rhesus macaques against each pseudotyped virus. The NT50 titer in (c) and (e) was defined as the reciprocal of serum dilution at which nAbs caused 50% inhibition of infection. Data in (c) were analyzed by the Friedman test with Dunn’s multiple comparisons test (n = 49). ***p < 0.001. Data in (e) represented as the mean ± SEM (n = 4). Adjusted p values were calculated by two-way ANOVA with Tukey’s multiple comparisons test *p < 0.05

Similar articles

Cited by

References

    1. Tegally, H. et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv, 2020.2012.2021.20248640, 10.1101/2020.12.21.20248640 (2020).
    1. Kemp, S. et al. Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/ΔV70. bioRxiv, 2020.2012.2014.422555, 10.1101/2020.12.14.422555 (2020).
    1. Page, A. J. et al. Large scale sequencing of SARS-CoV-2 genomes from one region allows detailed epidemiology and enables local outbreak management. medRxiv, 2020.2009.2028.20201475, 10.1101/2020.09.28.20201475 (2020). - PMC - PubMed
    1. Volz, E. et al. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity. Cell, 10.1016/j.cell.2020.11.020 (2020). - PMC - PubMed
    1. Zhang L, et al. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat. Commun. 2020;11:6013. doi: 10.1038/s41467-020-19808-4. - DOI - PMC - PubMed

Substances